Targeting heterogeneous nuclear ribonucleoparticule A1 and A2 proteins by RNA interference promotes cell death in transformed but not in normal mouse cell lines
Related Experiment Video
Updated: Aug 21, 2026

Establishing Cell Lines Overexpressing DR3 to Assess the Apoptotic Response to Anti-mitotic Therapeutics
Published on: January 11, 2019
Caroline Patry1, Bruno Lemieux, Raymund J Wellinger
1Département de Microbiologie et d'Infectiologie, Faculté de Médecine, Université de Sherbrooke, 3001 12th Avenue Nord, Sherbrooke, Quebec J1H 5N4, Canada.
Abstract:
The heterogeneous nuclear ribonucleoparticule A1 and A2 proteins can bind to vertebrate single-stranded telomeric sequences. Moreover, changes in the levels of heterogeneous nuclear ribonucleoparticule A1 can influence telomere length in mouse and human cells. We have shown previously that the combined knockdown of A1 and A2 proteins in human transformed cells promotes apoptosis. In contrast, a similar reduction in A1 and A2 expression in normal mortal human cell lines does not induce cell death. Here, we show that a variety of mouse cell lines display a similar behavior on reduction of A1 and A2 protein levels using small interfering RNA. In addition, the expression of the mouse A1 cDNA protects human HeLa cells from apoptosis when human A1 and A2 proteins are targeted by RNA interference. Lastly, we show that knockdown of A1 and A2 expression also impairs the growth of a human transformed cell line that does not express telomerase. These results firmly establish A1 and A2 as proteins required for the viability of transformed murine and human cells, irrespective of the status of telomerase expression or the length of the double-stranded telomeric repeat.
Insights
Heterogeneous nuclear ribonucleoparticle A1 and A2 proteins are essential for the survival of transformed mouse and human cells. Their reduction induces apoptosis in cancer cells but not normal cells, regardless of telomerase activity.
Area of Science:
- Molecular Biology
- Cell Biology
- Genetics
Background:
- Heterogeneous nuclear ribonucleoparticle (hnRNP) A1 and A2 proteins bind to telomeric sequences.
- hnRNP A1 levels affect telomere length in human and mouse cells.
- Previous studies indicated hnRNP A1/A2 knockdown induces apoptosis in human transformed cells but not normal cells.
Purpose of the Study:
- To investigate the role of hnRNP A1 and A2 proteins in cell viability across different cell types and conditions.
- To determine if mouse cells exhibit similar responses to hnRNP A1/A2 reduction as human cells.
- To assess the necessity of hnRNP A1/A2 for the growth of telomerase-negative transformed cells.
Main Methods:
- Small interfering RNA (siRNA) was used to reduce hnRNP A1 and A2 protein levels in various mouse and human cell lines.
- Mouse A1 cDNA was expressed in human HeLa cells to assess its protective effect against apoptosis.
- Cell viability and growth were monitored following protein knockdown.
Main Results:
- Mouse cell lines showed similar apoptotic responses to hnRNP A1/A2 reduction as observed in human transformed cells.
- Expression of mouse A1 cDNA conferred protection against apoptosis in human cells undergoing hnRNP A1/A2 knockdown.
- Knockdown of hnRNP A1/A2 impaired the growth of a human transformed cell line lacking telomerase expression.
Conclusions:
- hnRNP A1 and A2 proteins are crucial for the viability of both murine and human transformed cells.
- The requirement for hnRNP A1/A2 is independent of telomerase expression status.
- These proteins are essential for maintaining the integrity and proliferation of cancer cells, irrespective of telomere length.
More Related Videos
Related Concept Videos
Experimental RNAi
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
MicroRNAs
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
In-vitro Mutagenesis

